Gene · 3451
Papers2,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GADD45A and GADD45B as Novel Biomarkers Associated with Chromatin Regulators in Renal Ischemia-Reperfusion Injury. | Int J Mol Sci | 2023 | 37511062 | PubTator, text mining | PubMed |
| Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. | Sci Immunol | 2023 | 37506197 | PubTator, text mining | PubMed |
| Application of Circulating Tumor Cells and Interleukin-6 in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer. | J Inflamm Res | 2023 | 37497064 | PubTator, text mining | PubMed |
| Production of Rhizopus oryzae lipase using optimized Yarrowia lipolytica expression system. | FEMS Yeast Res | 2023 | 37496194 | PubTator, text mining | PubMed |
| Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. | Nat Med | 2023 | 37488287 | PubTator, text mining | PubMed |
| A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors. | Front Immunol | 2023 | 37483633 | PubTator, text mining | PubMed |
| Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis. | Lupus Sci Med | 2023 | 37460249 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Liver immunopathogenesis in fatal cases of dengue in children: detection of viral antigen, cytokine profile and inflammatory mediators. | Front Immunol | 2023 | 37457689 | PubTator, text mining | PubMed |
| Characterizing distinct profiles of immune and inflammatory response with age to Omicron infection. | Front Immunol | 2023 | 37457688 | PubTator, text mining | PubMed |
| Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities. | Res Rep Urol | 2023 | 37456804 | PubTator, text mining | PubMed |
| Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft. | Explor Target Antitumor Ther | 2023 | 37455824 | PubTator, text mining | PubMed |
| GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma. | J Cell Mol Med | 2023 | 37448185 | PubTator, text mining | PubMed |
| A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon IFNA5 in Lupus Nephritis. | Int J Mol Sci | 2023 | 37445814 | PubTator, text mining | PubMed |
| The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures. | Int J Mol Sci | 2023 | 37445723 | PubTator, text mining | PubMed |
| Dysfunction of Inflammatory Pathways and Their Relationship with Anti-Hypothalamic Autoantibodies in Patients with Anorexia Nervosa. | Nutrients | 2023 | 37432371 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell therapy for the treatment of systemic rheumatic diseases: a comprehensive review of recent literature. | Ann Med Surg (Lond) | 2023 | 37427200 | PubTator, text mining | PubMed |
| Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning. | Front Pharmacol | 2023 | 37426809 | PubTator, text mining | PubMed |
| Stress to inflammation and anhedonia: Mechanistic insights from preclinical and clinical models. | Neurosci Biobehav Rev | 2023 | 37419230 | PubTator, text mining | PubMed |
| iProMix: A mixture model for studying the function of ACE2 based on bulk proteogenomic data. | J Am Stat Assoc | 2023 | 37409267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3451/papers?page=10